{"DataElement":{"publicId":"2778888","version":"3","preferredName":"Patient Uncontrolled Concurrent Disease or Disorder Exclusion Criteria Ind-2","preferredDefinition":"the yes/no indicator whether any uncontrolled abnormal condition that occurs during the course of a clinical study as a medical and/or social characteristic prevents a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","longName":"PT_UNC_CON_DZ_EXC_IN","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2778874","version":"1","preferredName":"Patient Uncontrolled Concurrent Disease or Disorder Exclusion Criteria","preferredDefinition":"information related to any uncontrolled abnormal condition that occurs during the course of a clinical study as a medical and/or social characteristic that prevents a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","longName":"PT_UNC_CON_DZ_EXC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778872","version":"1","preferredName":"Uncontrolled Concurrent Disease or Disorder Exclusion Criteria","preferredDefinition":"Not controlled, regulated, or constrained.:Occurring or operating at the same time.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Exclusion; the act of restricting entrance or barring from participation.","longName":"C48932:C25456:C2991:C25370","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uncontrolled","conceptCode":"C48932","definition":"Not controlled, regulated, or constrained.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Concurrent","conceptCode":"C25456","definition":"Occurring or operating at the same time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"558809BB-EF22-4D54-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-28","modifiedBy":"ONEDATA","dateModified":"2008-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"558809BB-EF33-4D54-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000501","version":"1","longName":"GOG-0170Q","context":"NRG"},{"publicId":"4104902","version":"1","longName":"GOG-0170Q","context":"NRG"},{"publicId":"10000502","version":"1","longName":"GOG-0170Q","context":"NRG"}]},{"publicId":"6162769","version":"1","longName":"University of Rochester","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6337044","version":"1","longName":"URCC Forms","context":"NCIP"}]}],"AlternateNames":[{"name":"PT_UNC_CON_DZ_EXC_IND","type":"COG Form Element","context":"COG"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"GOG","type":"USED_BY","context":"NRG"},{"name":"PT_UNC_CON_DZ_EXC_IN","type":"USED_BY","context":"NRG"},{"name":"PT_UNC_CON_DZ_EXC_IN","type":"USED_BY","context":"Alliance"},{"name":"PT_UNC_CON_DZ_EXC_IN","type":"USED_BY","context":"CITN"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"PT_UNC_CON_DZ_EXC_IN","type":"USED_BY","context":"CCTG"},{"name":"NCIP","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Uncontrolled intercurrent ill","type":"Preferred Question Text","description":"Uncontrolled intercurrent illness","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, or psychiatric illness/social situations that would limit compliance with study requirements","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"No uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Any of the following: \r\n- History of significant ventricular arrhythmia in the last 5 years including: ventricular tachycardia or ventricular fibrillation \r\n-  QTc prolongation on baseline ECG (defined as a QTc interval >450 msec for males and QTc interval >470 msec for females \r\n- Currently using a medication known to cause prolonged QTc (See Appendix III) which can not be discontinued\r\nNote: Other medications with possible risk of prolonged QTc are allowed but should be used with caution. Patients using these medications should be monitored accordingly. See Appendix IV. \r\n- Ventricular arrhythmia on baseline ECG (ventricular tachycardia or ventricular fibrillation >= 3 beats in a row). \r\n- Second or third degree heart block\r\n","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Uncontrolled intercurrent illness including, but not limited to: ongoing or active infection symptomatic congestive heart failure unstable angina pectoris cardiac arrhythmia severely impaired lung function uncontrolled diabetes as defined by fasting serum glucose >1.5 x ULN (Note: Optimal glycemic control should be achieved before starting trial therapy.) psychiatric illness/social situations that would limit compliance with study requirements liver disease such as cirrhosis or severe hepatic impairment chronic active hepatitis chronic persistent hepatitis or history of hepatitis B or C","url":null,"context":"CTEP"},{"name":"AECC Text 1","type":"Alternate Question Text","description":"Does patient have ongoing or active infection?","url":null,"context":"AECC"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Has the patient had a serious uncontrolled medical illness or disorder, abdominal surgery (for reasons other than IP port placement) or active infection within four weeks of study entry?","url":null,"context":"CTEP"},{"name":"CRF Text 9","type":"Alternate Question Text","description":"Uncontrolled primary tumor site?(breast, prostate, or lung)","url":null,"context":"CTEP"},{"name":"CRF text 8","type":"Alternate Question Text","description":"Uncontrolled intercurrent illness including, but not limited to, unstable angina pectoris, cadiac arrhythmia, congestive heart failure, psychiatric illness/social situations that would limit compliance with study requirements, or medical or psychiatric illness that would, in the opinion of the investigator, preclude participation in the study or the ability of patients to provide informed consent for themselves","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Patients with symptomatic disease which meets the following criteria of BPI score greater than or equal to 3 and one of the following: inability to control pain with NSAIDs and considering addition of narcotics, >30% increase in current use of narcotics, or addition of a new opioid narcotic.","url":null,"context":"CTEP"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"Active and/or uncontrolled infection, including active hepatitis","url":null,"context":"CTEP"},{"name":"GOG_CRF Text","type":"Alternate Question Text","description":"Does the patient have concurrent severe medical problems unrelated to the malignancy that would significantly limit full compliance with the study or expose the patient to extreme risk or decreased life expectancy?","url":null,"context":"NRG"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Does patient have uncontrolled intercurrent illness that would limit compliance with study requirements?","url":null,"context":"CTEP"},{"name":"NRG_CRF text","type":"Alternate Question Text","description":"Does the patient have any uncontrolled illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure and unstable angina pectoris?","url":null,"context":"NRG"},{"name":"ACRIN - 1","type":"Alternate Question Text","description":"Does participant have any clinically significant ongoing, active or serious infection, symptomatic or uncontrolled congestive heart failure, active angina, symptomatic or uncontrolled cardiac arrhythmia or any other medical condition or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"ECOG-ACRIN"},{"name":"CITN 1","type":"Alternate Question Text","description":"Ongoing or active infection and/or treatment with systemic antibiotics or antifungals for ongoing or recurrent infection (topical use of antibiotics or antifungals is allowed).","url":null,"context":"CITN"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does patient have a known active infection of HBV?","url":null,"context":"CTEP"},{"name":"CRF_Text_10","type":"Alternate Question Text","description":"Does the patient have an uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, myocardial infarction within six months of protocol initiation?","url":null,"context":"CTEP"},{"name":"NRG CRF_Text2","type":"Alternate Question Text","description":"Does patient have chronic or current active infectious disease requiring systemic antibiotics, antifungal or antiviral treatment?","url":null,"context":"NRG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Does patient have uncontrolled infection?","url":null,"context":"COG"},{"name":"ABTC 1602","type":"Alternate Question Text","description":"Does the patient have any uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"CTEP"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"Does patient have a history of or a current condition that in the opinion of the investigator would preclude participation in this study?","url":null,"context":"NRG"},{"name":"MA39","type":"Alternate Question Text","description":"Patient has serious active or co-morbid medical conditions, laboratory abnormality, psychiatric illness, active or uncontrolled infections, or serious illnesses or medical conditions that would prevent the patient from participating or to be managed according to the protocol (according to investigator's decision).","url":null,"context":"CCTG"},{"name":"CRF Text 13","type":"Alternate Question Text","description":"Does the patient have uncontrolled intercurrent illness, including, but not limited to, ongoing or active infection, symptomatic congestive heart failure and unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"CTEP"},{"name":"CRF Text12","type":"Alternate Question Text","description":"In physician's judgement, patient's co-morbidities do not limit patient's participation in study interventions.","url":null,"context":"Alliance"},{"name":"CRF Text 14","type":"Alternate Question Text","description":"Does the patient have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, extensive interstitial bilateral lung disease on High Resolution Computer Tomography (HRCT) scan, or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"Does patient have any uncontrolled, intercurrent illness including but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, or cardiac arrythmia?","url":null,"context":"COG"},{"name":"NRG_CRF_Text 3","type":"Alternate Question Text","description":"Does the patient have any severe, active co-morbidities as detailed in section 3.3 of the protocol?","url":null,"context":"NRG"},{"name":"CRF_Text13","type":"Alternate Question Text","description":"Does the patient have an active Hepatitis B or C infection?","url":null,"context":"NRG"},{"name":"CRF Text 15","type":"Alternate Question Text","description":"Does the patient have an active or uncontrolled systemic infection?","url":null,"context":"CTEP"},{"name":"NRG_CRF_Text4","type":"Alternate Question Text","description":"Does the patient have any severe, active co-morbidities as detailed in section 3.2 of the protocol?","url":null,"context":"NRG"},{"name":"QText 1","type":"Alternate Question Text","description":"Known impaired liver function as assessed by the treating physician?","url":null,"context":"NRG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Does patient have active uncontrolled infection?","url":null,"context":"COG"},{"name":"CRF Text 16","type":"Alternate Question Text","description":"Does the patient have an active (with the exception of uncomplicated urinary tract infection) or uncontrolled systemic infection?","url":null,"context":"CTEP"},{"name":"COG CRF Text 17","type":"Alternate Question Text","description":"Does patient have active or chronic infection within 7 days prior to study entry?","url":null,"context":"COG"},{"name":"Have any type of unstable comorbid medical or psychiatric condition that would prohibit completion of study assessments or intervention per physician or physician's designee","type":"Alternate Question Text","description":"Have any type of unstable comorbid medical or psychiatric condition that would prohibit completion of study assessments or intervention per physician or physician's designee","url":null,"context":"NCIP"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Does the patient have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia (other than atrial fibrillation with controlled ventricular rate), or psychiatric illness/social situations that would limit compliance with study requirements, or substantially increase the risk of incurring adverse events or compromise the ability of the patient to given written informed consent?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does the patient have uncontrolled intercurrent illness?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text 5","type":"Alternate Question Text","description":"Does the patient have any severe, active co-morbidities as detailed in section 3.2.5 of the protocol?","url":null,"context":"NRG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Does patient have an uncontrolled concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"COG"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Does the patient have any known uncontrolled intercurrent illness such as infection, autoimmune conditions, cardiac arrhythmias, angina pectoris, and gastrointestinal disorders affecting swallowing and/or absorption of pills that would jeopardize the patient's safety?","url":null,"context":"COG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Does the patient have any severe, active co-morbidities as detailed in section 3.2.9 of the protocol?","url":null,"context":"NRG"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55879EB0-A07F-5D25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-28","modifiedBy":"TSESU","dateModified":"2023-07-07","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2023.3.17 AQT added per ticket request CADSR0002164. ak 7/20/2022: fixed the box symbol in AQTs.wz  2022.10.4 AQT added for ticket request CADSR0001571. ak","unresolvedIssues":null,"deletedIndicator":"No"}}